tiprankstipranks
Voyager Therapeutics Inc. (VYGR)
:VYGR
US Market

Voyager Therapeutics (VYGR) Income Statement

Compare
677 Followers

Voyager Therapeutics Income Statement

Last quarter (Q3 2024), Voyager Therapeutics's total revenue was $24.63M, an increase of 433.79% from the same quarter last year. In Q3, Voyager Therapeutics's net income was $-9.04M. See Voyager Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 250.01M$ 40.91M$ 37.41M$ 171.13M$ 104.39M
Gross Profit
$ 245.57M$ 34.72M$ -36.37M$ 62.38M$ -15.34M
Operating Expenses
$ 127.99M$ 91.74M$ 111.03M$ 143.74M$ 156.07M
Depreciation and Amortization
$ 4.44M$ 6.19M$ 5.17M$ 3.82M$ 2.77M
EBITDA
$ 126.45M$ -44.65M$ -68.45M$ 31.20M$ -48.91M
Operating Income
$ 122.01M$ -50.84M$ -73.62M$ 27.38M$ -51.68M
Other Income/Expenses
$ 11.72M$ 4.45M$ 2.42M$ 9.36M$ 8.08M
Pretax Income
$ 133.74M$ -46.39M$ -71.20M$ 36.74M$ -43.60M
Net Income
$ 132.33M$ -46.41M$ -66.03M$ 36.74M$ -40.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.08$ -1.21$ -1.75$ 0.99$ -1.14
Diluted EPS
$ 2.97$ -1.21$ -1.75$ 0.98$ -1.14
Weighted Average Shares Outstanding
43.02M 38.36M 37.67M 37.13M 35.90M
Weighted Average Shares Outstanding (Diluted)
44.57M 38.36M 37.67M 37.35M 35.90M
Currency in USD

Voyager Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis